Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 35 for “"Liposarcoma"”.
-
Therapeutic targets in dedifferentiated liposarcoma
… at i) unravelling whether well differentiated liposarcoma (WDLPS) undergo a progressive evolution to dedifferentiated liposarcoma (DDLPS) through the analysis of the transcriptomic profile of retroperitoneal liposarcoma; ii) identifying and validating therapeutic targets for DDLPS including the …
-
The FUS-DDIT3 interactome in myxoid liposarcoma
Myxoid liposarcoma is a malignant fatty tumour that develops in the deep soft tissue. While local control rates are good, current chemotherapy options remain ineffective against metastatic disease. Myxoid liposarcoma is characterized by a balanced translocation involving FUS (12q13) and DDIT3 …
-
Identifying new driver genes in well differentiated retroperitoneal liposarcoma
Introduction: Well differentiated retroperitoneal liposarcoma (WDLS) has a high local recurrence rate, a poor response to neoadjuvant therapy and has the potential to become a high-grade dedifferentiated tumour (DDLS). Efforts to target the hallmark MDM2 and CDK4 amplification have been met with …
-
Identifying novel druggable targets in dedifferentiated liposarcoma using biological networks
Dedifferentiated liposarcoma (DDLPS) is a rare and aggressive adult soft tissue malignancy with limited treatment options and high relapse rates following surgical resection and radiotherapeutic interventions. DDLPS are characterised by amplifications of the MDM2 and CDK4 genes. Consequently, these …
-
Development of a Novel Prime-Boost Immunotherapy for Dedifferentiated Liposarcoma
… of a high grade and aggressive dedifferentiated liposarcoma (DDLS) using gene expression profiling and immunohistochemistry. We gained valuable insights into the tumor biology and the complex immunological mechanisms within the tumor immune microenvironment. Notably, we identified a novel antigen …
-
Targeting The Mdm2-P53 Axis For The Treatment of Dedifferentiated Liposarcoma
Dedifferentiated liposarcoma (DDLPS) is an aggressive malignancy characterized by a high rate of recurrence and dismal patient outcome. Minimal improvement in patient survival has been made in the last several decades, highlighting the crucial need for improved therapeutic strategies. A better …
-
Myxoid Liposarcoma: Models and Mechanisms of Sarcomagenesis and Response to Radiation Therapy
<p>Myxoid liposarcoma (MLPS) is a malignant soft tissue sarcoma characterized by a pathognomonic t(12;16)(q13;p11) translocation that produces a fusion oncoprotein, FUS-CHOP. This cancer is remarkably sensitive to radiotherapy and exhibits a unique pattern of extrapulmonary metastasis. However, the …
-
Multi-omics Characterisation of Myxoid Liposarcoma and Investigation of Trabectedin Mechanism of Action for Its Treatment
Myxoid liposarcoma (MLPS) is a rare soft tissue sarcoma of the mesenchymal cells characterised by the expression of the FUS-DDIT3 oncoprotein that impairs the adipocyte differentiation. Among the available therapeutic choices for the treatment of MLPS, trabectedin has shown significant anti-tumour …
-
Gerai diferencijuotos liposarkomos galūnėse diagnostika ir gydymas: dėmesys petinio nervų rezginio srities navikams. Literatūros apžvalga ir atvejo aprašymas /
… treatment alternatives for a well-differentiated liposarcoma of the extremities; to provide a detailed analysis of the challenges in the management of tumor located near to the brachial plexus. To make a recommendation list for the diagnosis and treatment of a well-differentiated liposarcoma in …
-
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
… more promise than others: dedifferentiated liposarcoma (DDLPS) and undifferentiated pleomorphic sarcoma (UPS). Another issue plaguing the field of STS is that there is no universal indicator of response. The percentage of hyalinization found within the tumor was recently identified as a …
-
QN-302-Mediated G-Quadruplex Stabilisation in Liposarcoma: A Dual Hit Strategy to Restore p53 and Reprogram Innate Immune Response
Dedifferentiated liposarcoma (DDLPS) is a rare and aggressive soft tissue sarcoma (STS) characterised by poor prognosis and limited therapeutic options. A defining molecular hallmark of DDLPS is the amplification of the 12q13–q15 chromosomal region, leading to the pathological overexpression of the …
-
In situ proximity ligation assays in the study of FET fusion oncoprotein interactions in sarcoma cells
… oncoproteins, such as FUS::DDIT3 in myxoid liposarcoma. These fusion oncoproteins alter gene expression through aberrant interactions with chromatin-regulating proteins, including SWI/SNF chromatin remodeling complex and transcriptional co-activator BRD4. Understanding these interactions at …
-
TELOMERE MAINTENANCE MECHANISMS IN TUMOR OF MESENCHYMAL ORIGIN: EVALUATION OF PROGNOSTIC SIGNIFICANCE AND CHARACTERIZATION OF RELEVANT MOLECULAR PATHWAYS
… nerve sheath tumors –MPNST-, leiomyosarcoma, liposarcoma) and mixed origin tumours (Wilms’ tumour), showing the relatively low frequency of telomerase activity in soft tissue sarcomas if compared to tumors of epithelial origin, and the important role of ALT in these malignancies. Controversial …
-
Mode of Action of Trabectedin in Human Mixoid Liposarcoma Growing in Immunodeficient Mice: Evidence that the Drug Acts by Displacing FUS-CHOP Chimeric Protein From its Target Promoters
… 2 line therapy of ovarian cancer in 2009. Myxoid liposarcoma (ML) is a specific histological subtype within the family of adults soft tissue sarcomas. Specifically >90% of usual myxoid/round cell liposarcomas (ML/RCLS) are characterized by the chromosomal translocation t(12;16) (q13; p11), which …
-
Διερεύνηση διαγνωστικών και προγνωστικών υπογραφών έκφρασης MicroRnas στα λιποσαρκώματα
… influence at specific molecular processes in liposarcomas development , as well as in other subtypes of sarcomas, affecting the metastatic potential, differentiation, apoptosis and other essential cellular functions suggesting candidates molecules for investigation in our study. Moreover ,in …
-
Γενετικές αναλύσεις μεσεγχυματογενών όγκων και συσχετίσεις με κλινικοπαθολογικές παραμέτρους
… to the conclusions made, because we analysed 12 liposarcomas, 4 synovial sarcomas and 5 Ewing sarcomas by detecting the fusion genes FUS/CHOP, SYT/SSX and EWS/FLI, which are diagnostic markers. We also detected new chromosomal aberrations and the precise chromosome breakpoints that can lead to …
-
Biochemical fractionation of induced pluripotent stem cell derived motor neurons from an ALS patient with the Glycine-298-Serine TDP-43 mutation
… (TDP-43), and fused in sarcoma/translocated in liposarcoma (FUS/TLS) form protein aggregates in amyotrophic lateral sclerosis (ALS) and fronto-temporal lobar degeneration (FTLD). The sequencing of the TDP-43 gene TARDBP in a large patient population has shown more than 40 missense mutations that …
Page 1 of 2